By rray, 19 October, 2023 Offer supportive care and pain control Monitor lesions for secondary bacterial infection
By rray, 19 October, 2023 If perinatal contact between pt in isolation and their newborn not advised due to risk of severe dz in infant consider separate rooms delay breastfeeding until criteria to d c isolation have been met If the pt chooses to have contact w the newborn during
By rray, 19 October, 2023 Person may be contagious during this period and should isolate Follow isolation and prevention practices x5 days If no new s sx including rash develop stop isolation and prevention practices Monitor for the remainder of the 21 day period If additional s s
By rray, 19 October, 2023 Characteristic rash deep seated and well circumscribed lesions often w central umbilication and lesion progression through specific sequential stages macules papules vesicles pustules and scabs 2 sometimes confused w other more common diseases e g seconda
By rray, 19 October, 2023 A case may be excluded if an alternative dx can fully explain the illness OR an individual w sx consistent w mpox doesn t develop a rash w in 5 days of illness onset OR high quality specimens don t demonstrate the presence of Orthopoxvirus or mpox virus o
By rray, 19 October, 2023 Postexposure monitoring in community Monitor x21 days 2 Perform thorough skin and mucosal e g anal vaginal oral exam for the characteristic vesiculopustular rash of mpox this allows for detection of lesions the pt may not have been aware of 7 Instruct pt
By rray, 19 October, 2023 ACAM2000 2nd gen live vaccine Contraindicated in pregnant immunocompromised HIV
By rray, 19 October, 2023 Jynneos 3rd gen vaccine is preferred option Safe in people w HIV 2 Administer in 2 doses 0 1 mL intradermally or 0 5 mL SC 28 days apart